| 9:30am – 10:00am | Registration and Continental Breakfast |
| 10:00am – 10:30am | Welcome and Introductions Bob Langer, Pablo Legorreta, and Andrew W. Lo |
| 10:30am – 11:45am | Recent Innovations and Funding Needs Ed Benz (Dana Farber Cancer Institute), Bruce Chabner (MGH), Jeffrey Flier (Harvard Medical School), Manolis Kellis (MIT), Phil Sharp (MIT Koch Institute), Bob Weinberg (Whitehead Institute and MIT Koch Institute) |
| 11:45am – 12:00pm | Break |
| 12:00pm – 1:00pm | Lunch Discussion: The Evolving Role of Nonprofits Louis DeGennaro (Leukemia & Lymphoma Society), Ken Schaner (Schaner & Lubitz), Christiana Stamoulis (Unum Therapeutics) |
| 1:00pm – 2:00pm | Pharma/Bioetch/Academic Perspectives Belen Carrillo-Rivas (Pfizer), Doug Cole (Flagship Ventures), Alan Crane (Polaris Partners), Ansbert Gadicke (MPM Capital), Marc Tessier-Lavigne (Rockefeller University), Robert Urban (J&J) |
| 2:00pm – 2:15pm | Break |
| 2:15pm – 3:15pm | Potential Business/Financing Structures Mark Chalek (Beth Israel Deaconess Medical Center), Jennifer Goldstein (Silicon Valley Bank), Edward Jung (Intellectual Ventures), Lita Nelsen (MIT), Katrina Niehaus (Goldman Sachs), Issi Rozen (Broad Institute) |
| 3:15pm – 3:30pm | Break |
| 4:30pm – 5:00pm | Wrap-Up and Next Steps |
